Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02Jun 10, 2025
Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
Evotec
PR-M04-21-020Apr 20, 2021
Collaboration
Evotec and Bristol-Myers Squibb Expand iPSC Collaboration
Evotec
PR-M01-20-NI-018Jan 14, 2020
M&A
Evotec And Venture Capital Consortium Form 'Breakpoint Therapeutics Gmbh'
Evotec
PR-M07-19-NI-022Jul 10, 2019
Artificial Intelligence
Sensyne Health, Evotec, OSI and the University of Oxford Create New Partnership Called LAB10x to Accelerate Data-Driven Drug Discovery Powered by AI
Huma
PR-M06-19-NI-049Jun 27, 2019
Research
Evotec Forms Academic Bridge 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
Evotec
PR-M06-18-NI-014Jun 05, 2018
Collaboration
Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines
Evotec
PR-M06-18-NI-002Jun 01, 2018
Strategic Partnership
Evotec and Celgene Enter into Strategic Oncology Partnership
Evotec
PR-M05-18-NI-091May 24, 2018
Strategic Collaboration
Evotec and Carna Biosciences Collaborate on Indigo Platform
Evotec
PR-M05-18-NI-047May 11, 2018
Expansion
Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
Evotec
PR-M05-18-NI-023-4319May 07, 2018